Who owns CVS HEALTH Corp?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CVS from SEC Form 13F filings across 1,987 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 1,987 institutions disclosed 1.11B shares of CVS HEALTH Corp worth $94.99B — about 86.5% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
1,987
13F holders
$94.99B
value, 2026 filers
86.5%
of shares outstanding (1.11B sh)
173
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of CVS's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 120.4M | $10.32B | 0.2% | 9.4% | -2.3% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 83.7M | $7.17B | 0.2% | 6.5% | +0.4% |
| 3 | Capital World Investors | 74.0M | $6.35B | 0.8% | 5.8% | -1.2% |
| 4 | STATE STREET CORP | 60.1M | $5.15B | 0.1% | 4.7% | -0.3% |
| 5 | Dodge & Cox | 46.0M | $3.95B | 2.1% | 3.6% | -7.9% |
| 6 | WELLINGTON MANAGEMENT GROUP LLP | 36.7M | $3.14B | 0.6% | 2.9% | +8.5% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 30.9M | $2.64B | 0.1% | 2.4% | +3.4% |
| 8 | VANGUARD PORTFOLIO MANAGEMENT LLC | 27.1M | $2.32B | 0.1% | 2.1% | +1.8% |
| 9 | FMR LLC | 24.9M | $2.13B | 0.1% | 1.9% | -14.0% |
| 10 | BANK OF AMERICA CORP /DE/ | 23.6M | $2.02B | 0.1% | 1.8% | +1.8% |
| 11 | JPMORGAN CHASE & CO | 22.1M | $1.93B | 0.1% | 1.7% | +0.1% |
| 12 | Capital Research Global Investors | 21.9M | $1.87B | 0.3% | 1.7% | -10.2% |
| 13 | PRICE T ROWE ASSOCIATES INC /MD/ | 21.7M | $1.86B | 0.2% | 1.7% | -10.5% |
| 14 | Invesco Ltd. | 21.6M | $1.85B | 0.1% | 1.7% | +5.0% |
| 15 | MORGAN STANLEY | 18.2M | $1.56B | 0.1% | 1.4% | -2.2% |
| 16 | Capital International Investors | 14.9M | $1.28B | 0.3% | 1.2% | -3.3% |
| 17 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 12.8M | $1.10B | 0.1% | 1% | -3.4% |
| 18 | GOLDMAN SACHS GROUP INC | 12.8M | $1.10B | 0.1% | 1% | -4.7% |
| 19 | NORTHERN TRUST CORP | 12.0M | $1.03B | 0.1% | 0.9% | +4.5% |
| 20 | Davis Selected Advisers | 11.9M | $1.02B | 4.4% | 0.9% | +0.3% |
| 21 | PZENA INVESTMENT MANAGEMENT LLC | 10.3M | $882.3M | 2.6% | 0.8% | -12.5% |
| 22 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 9.6M | $825.5M | 0.4% | 0.8% | +90.0% |
| 23 | Legal & General Group Plc | 9.0M | $774.1M | 0.2% | 0.7% | -1.5% |
| 24 | Bank of New York Mellon Corp | 9.0M | $773.9M | 0.1% | 0.7% | +0.2% |
| 25 | AMERIPRISE FINANCIAL INC | 8.9M | $758.8M | 0.2% | 0.7% | +11.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.